- Open Access
Effect of ω-3 and ω-9 fatty acid rich oils on lipoxygenases and cyclooxygenases enzymes and on the growth of a mammary adenocarcinoma model
© Comba et al; licensee BioMed Central Ltd. 2010
- Received: 24 September 2010
- Accepted: 8 October 2010
- Published: 8 October 2010
Nutritional factors play a major role in cancer initiation and development. Dietary polyunsaturated fatty acids (PUFAs) have the ability to induce modifications in the activity of lipoxygenase (LOX) and cyclooxygenase (COX) enzymes that affect tumour growth. We studied the effect of two diets enriched in 6% Walnut and Peanut oils that are rich in ω-3 and ω9 PUFAs respectively on a murine mammary gland adenocarcinoma as compared with the control (C) that received commercial diet.
Peanut oil enriched diet induced an increase in membrane arachidonic acid (AA) content and the cyclooxygenase enzyme derived 12-HHT (p < 0.05) and simultaneously showed decrease in 12-LOX, 15-LOX-2, 15-LOX-1 and PGE activities (p < 0.05) that corresponded to higher apoptosis and lower mitosis seen in this group (p < 0.05). Furthermore, Peanut oil group showed lower T-cell infiltration (p < 0.05), number of metastasis (p < 0.05) and tumour volume (p < 0.05) and longer survival rate compared to other groups.
The results of the present study showed that Peanut oil-enriched diet protects against mammary cancer development by modulating tumour membrane fatty acids composition and LOX and COX enzyme activities.
- Arachidonic Acid
- Tumor Cell Membrane
- Free Arachidonic Acid
Epidemiological studies showed that breast cancer incidence is increasing and is the third leading cause of death due to cancer . Of all the environmental factors, nutrition has a significant role in the initiation and progression of breast cancer . Dietary ω-3 and ω-6 polyunsaturated fatty acids (PUFAs) have been shown to play an important role in human breast, colon, prostate, pancreas, and stomach cancers . Several studies suggested that ω-3 and ω-6 PUFAs are cytotoxic to different types of cancer cells and may act synergistically with current chemotherapeutic drugs .
Arachidonic acid (20:4, ω-6, AA) derived from the dietary essential fatty acid linoleic acid (18:2 ω-6, LA) can induce apoptosis of tumor cells by its ability to convert sphingomyelin to ceramide that triggers the release of pro-apoptotic proteins . In addition, AA is converted by the catalytic activities of cyclooxygenase (COX), lipoxygenase (LOX) and cytochrome P450 (CYP450) enzymes to several eicosanoids that have potent biological actions . Eicosanoids may act as active carcinogens or tumour promoters in view of their pro-inflammatory actions and by modulating the expression of various oncogenes and anti-oncogenes and thus, participate in cancer development [7, 8]. Hence, inhibition or modulation of the AA cascade may suppress inflammatory events to bring about their anti-carcinogenic effects. Tumour cell-derived PGE2 inhibit the production of immune regulatory lymphokines, T-cell and B cell proliferation, and the cytotoxic activity of natural killer cells, thus favoring tumour growth . Dietary manipulation of lipid sources may induce modification of PUFAs composition and physical properties of cell membranes that, in turn, influence eicosanoid synthesis and thus, affect tumour growth. Hence, we studied the effects of two dietary oils, one enriched in ω-3 and ω-6 from Walnuts and the other from Peanuts rich in ω-6 and ω-9 PUFAs on LOX and COX enzyme activities and their influence on the growth of a murine mammary gland adenocarcinoma and the results are reported here.
Plant material, oil extraction and analysis
Walnut (Juglans regia L. var. Chandler) and Peanut (Arachis hypogaea L., Runner market type) seeds were obtained from local markets of Argentina. Oils were extracted according to the procedure described by Tobares et al.
Murine transplantable mammary adenocarcinoma (M3) in weaning BALB/c mice was used in the present study. M3 tumour is associated with 40% incidence of lung metastasis with a latency period of 6 ± 2 days after inoculation . Three months after feeding the experimental animals with Walnut and Peanut oils, mice were inoculated with the tumour. Transplantation of tumours and other animal studies were conducted in accordance with the guidelines of the National Institutes of Health (NIH) Guide for the Care and Use of Laboratory Animals and all the procedures were approved by the Animal Research Committee of the Institute of Oncology A.H. Roffo, Buenos Aires, Argentina.
Diets, Feeding Protocol, M3 tumour inoculum, Tumour Analysis
Fatty acids composition of Commercial diet, Walnut and Peanut oils. Fatty acids were determined as indicated in Methods section.
Saturated Fatty Acids
Unsaturated Fatty Acids
Sixty post-weaned male and female BALB/c mice were randomly distributed among three groups (20 mice each). Food and water were provided ad libitum. Animals were kept in a light and temperature-controlled room. After three months of feeding with respective diets, mice were inoculated subcutaneously with 1 mm3 of tumour tissue and were sacrificed 35 days after the inoculation of the tumor. At the end of the study, tumour volume was measured by a digital caliper and tumour cell (TC) suspensions were isolated from primary tumours for further studies . The number of macroscopic metastasis was recorded in all the organs of the three groups of animals with the aid of a magnifying lens.
Fatty acids analysis of oils and tumor cell membranes of animals fed Walnut and Peanut oils
Both Walnut and Peanut oils were subjected to alkaline saponification (1 N KOH) and the unsaponifiable matter was extracted with n-hexane and fatty acid methyl esters (FAME) were obtained using 1N sulfuric acid in methanol .
Tumor cell plasma membrane purification was achieved as described by Calderon et al . Briefly, tumor cells (1 × 106) were placed in homogenization solution (hypotonic Hepes-Manitol buffer) (Sigma-Aldrich, St. Louis, MO, USA) and homogenized using a Polytron (7 s. at setting 7). The homogenate was treated with 10 mM of CaCl2 and centrifuged at 3000 g for 15 min. The supernatant was saved and centrifuged at 48000 g for 30 min, and the pellet containing the plasma membrane fragments, was collected in deionized water and the lipids in the lower phase were extracted with chloroform: methanol: H2O (3:48:47 v/v). FAMEs were obtained with toluene and sodium metoxide at 4°C overnight .
The identification of the FAMEs was carried out by GLC using a capillary column of Polyethylene Glycol (30 m × 320 μm × 0.50 μm) (Phenomenex, Inc. U.S.A) using a Claurus 500 Perkin Elmers with an FID detector. FAME was identified by comparison of retention times with the corresponding commercial standards (Nu-Chek Prep, Inc. MN, U.S.A) .
LOXs and COXs Enzyme Activities in Tumours
The activities of 12-LOX, 15-LOX-2 and COX-2 with AA as the substrate and 15-LOX-1 with LA as the substrate were estimated as described previously by Kelavkar UP et al, with slight modifications . Briefly, tumour cell (TC) suspensions (1 × 107 TC/ml) were prepared from primary tumour that is free of necrotic areas, blood clots and connective tissue, with 0.01% pronase and 0.24% Type1-deoxyribonuclease in DMEM (Sigma-Aldrich, St. Louis, MO, USA) and were washed twice and resuspended in Ca2+ and Mg2+ free phosphate buffer saline (PBS) and stimulated with ionophore A23187 (2 M) (Sigma-Aldrich, St. Louis, MO, USA) for 15 min at 37°C. The metabolites were extracted using a STRATA C-18 cartridge (1 ml) (Phenomenex, Inc. U.S.A) and detected by Reverse-phase high performance liquid chromatography (HPLC). Analysis were conducted with a C18 Phenosphere-Next column (5 μm; 4.6 × 250 mm); (Phenomenex, Inc. U.S.A) equipped with a Beckman System Gold Programmable Module Model 126. Metabolic separation was achieved using a time program. A linear gradient from solvent A: methanol: water: acetic acid, 50:50:0.02 (v/v), pH 6 to solvent B: methanol, over 20 min. UV Programmable Detector Beckman System Gold Model 166 linked with a computer for data processing. UV analysis absorbance of the eicosanoid PGE2 was at 196 nm, and 12(S)-HHT, 12(S)-HETE, 15(S)-HETE and 13(S)-HODE was at 235 nm. Quantifications of eicosanoids PGE2, and 12(S)-HHT from COX-2 activity, and 12(S)-HETE, (12-LOX); 15(S)-HETE (15-LOX-2) and 13(S)-HODE (15-LOX-1) were obtained by using standard curves (Biomol International LP Plymouth Meeting, U.S.A) and expressed as (ng/1 × 107 TC) [16, 17].
Evaluation of Apoptosis and mitosis
Apoptosis of TC was analyzed by flow cytometry (FC) (Coulter® XL EPICS® Flow Cytometer), using an Annexin V- Fitc apoptosis detection kit (Sigma-Aldrich, St. Louis, MO, USA). The procedure is based on the binding properties of conjugated Annexin V-Fitc to plasma membrane phosphatidylserine (PS) in combination with propidium iodide (PI) staining . A complementary approach to evaluate the same parameters was performed by counting the apoptotic and mitotic figures in slides of tumour tissue of 10 animals for each dietary condition per 10 high-power fields scored descriptively or semiquantitatively in a blinded manner .
Tumour leukocyte infiltration index
This study was assayed using CD3 complex expressed on mature T lymphocytes and NK-T cells in tumour tissue sections (4 μm) as the markers. The cells were washed with PBS and incubated with the CD3 monoclonal hamster antimouse antibody (1:100 PBS) (BD Biosciences Pharmingen, Philadelphia, U.S.A), Immunoreactivity was revealed using an avidin-biotin-peroxidase technique (Vectastain Elite ABC kit; Vector Laboratories, Burlingame U.S.A). Infiltrating leukocytes positive for CD3 were counted in high power fields at × 400 and expressed as cells per unit area ± SEM (n [microscopic fields per section] = 10 .
Data obtained were analyzed using the ANOVA Test, and a generalized linear model with random component gamma, canonic link function (covariates) was used to evaluate the significance for diets, apoptosis, mitosis, eicosanoids, tumour leukocyte infiltration, tumour volume and metastases .
Tumour cell membrane Fatty Acid Analyses
Fatty acid profile of TC membranes from host bearing M3 adenocarcinoma fed on different diets.
Saturated Fatty acids
Unsaturated Fatty Acid
The percentage ω-3 PUFAs in Peanut TC membranes was lower (1.13%) in comparison to Walnut (4.90%) and Control (5.26).
The degree of membrane FA unsaturation (DBI/S) of Peanut TC membranes was significantly higher (2.50) than Walnut (1.50) and Control (1.27) dietary treatment (Table 2).
Effect of Diets on Tumour growth, Metastasis development and Animal Survival
Furthermore, mice from Peanut and Walnut groups showed the highest survival time (60 ± 4.92 and 52 ± 3.76 days after inoculum, respectively) compared to Control (38 ± 4.62 days) (p < 0.05) (Figure 2-c).
Effects of Diets on tumour cell proliferation and apoptosis
Number of apoptosis and mitosis recorded in tumour sections from hosts fed on the different dietary conditions.
3.3 ± 0.26 A
1.16 ± 0.12 A
2.62 ± 0.30 A
1.40 ± 0.12 A
1.56 ± 0.36 B
2.03 ± 0.14 B
Modulation of LOX and COX Enzymes of the ω-6 Pathway in tumour cells
Effect of ω-6, ω-3 and ω-9 dietary PUFAs on Tumour leukocyte infiltration index
Percentage of positive immunolabeling for CD3-T-lymphocytes and NK-T cells infiltration in tumor tissue.
% of Tumor Infiltration
29.23 ± 4.90A
16.71 ± 4.66A
3.03 ± 1.05B
Epigenetic factors have emerged as key mechanisms in cancer development. Of all the environmental factors, diet plays a critical role in the prevention and pathobiology of cancer . In the present, we evaluated whether post-weaning diet of mice modulates LOXs and COXs activities through the eicosanoid release and their impact on certain parameters related to a mammary gland adenocarcinoma development. The comparative analysis of the three dietary conditions showed that mice fed on similar supplemented ω-6 fatty acids diets differing in ω-9 and ω-3 content showed that ω-9 enriched Peanut oil diet exhibited a protective effect on tumour development in comparison to the other dietary oil treatments. It was noted that Peanut oil group showed the lowest number of mitosis, the highest amount of apoptosis, decreased leukocyte infiltration and increased survival time (Table 3 and Table 4; Figure 2 and Figure 3).
Unexpectedly, as shown in Table 2, Peanut oil treated tumor cell membranes exhibited the highest ω-6 AA levels compared to Walnut and Control (25.50 vs. 13.78 and 9.33 respectively) groups despite the fact that (Table 1) these oils do not contain any AA, while LA content of Walnut oil is the highest of the three oils used in the study (see Table 1). It is also surprising to note that even though the Walnut treated tumor cell membranes contained significantly higher amounts of 22:5 ω-3 fatty acid, the tumor volume and metastasis number were higher, survival of animals bearing the tumors was lower, and tumor cell apoptosis was less and tumor cell mitotic numbers were higher in this group compared to the Peanut oil treated group. These results suggest that presence of higher amounts of ω-6 AA in the tumor cell membrane is responsible for the beneficial effects seen.
It is known that dietary ω-6 LA is converted to AA by the action of Δ 6 and Δ 5 desaturases and the corresponding elongases. It is likely that the high levels of AA noted in Peanut group may be linked to the up-regulation of Δ6 and Δ 5 desaturases  that could explain the higher levels of unsaturated fatty acids in the tumor cell membranes  of Peanut oil treated group . AA forms substrate to COXs and LOXs enzymes and some of their metabolites are: 12(S)-HHT and PGE2via COXs; 12(S)-HETE and 15(S)-HETE via LOXs, while LA is a substrate for 15-LOX-1 and 13-HODE is its major metabolite. In the Peanut group, we observed the highest level of 12(S)-HHT, a lipoperoxide marker, and lower levels of PGE2 compared to control group. Both 12(S)-HHT and PGE2 are products of the activity of COX enzymes, whereas only PGE2 is formed due to the activity of the specific enzyme PGE synthase that explains changes in the levels of various eicosanoids in the cells. It has been shown that enhanced formation of lipid peroxides and low PGE2 production inhibit cancer progression and tumour growth . Moreover, the lower percentage of tumour leukocyte infiltration exhibited in Peanut group (Table 4) correlated well with the low PGE2 levels observed, which is considered as an activator of inflammatory process and related to pro-carcinogenic events . There is evidence to suggest that tumor infiltrating macrophages enhance tumor growth, promote tumor cell motility and angiogenesis [26, 27]. Though the exact mechanism(s) by which tumor-infiltrating macrophages enhance tumor growth is not clear, it is possible that these macrophages produce excess of PGE2, TNF-α and other pro-inflammatory molecules that aid tumor cell growth. PGE2 is derived from AA, while TNF-α enhances PGE2 production . On the other hand, PGE2 suppresses TNF-α production [29–32]. Inhibition of PGE2 synthesis was found to enhance TNF-α production and augment macrophage tumoricidal activity [29, 31]. In contrast, phospholipase A2 activity and AA was reported to be essential for the tumoricidal action of TNF-α [33–36]. It is known that both ω-3 and ω-6 fatty acids inhibit the production of TNF-α [37–39]. Thus, the relationship among PUFAs, eicosanoids and TNF-α and their actions on tumor cells is complex. In this complex net work of events, in general, PGE2 serves as an immunosuppressor and inhibits the tumoricidal action of macrophages; TNF-α needs phospholipase A2 activity and free AA to bring about its anti-tumor action; while free AA and other PUFAs have direct tumoricidal action [28–41].
In the present study, we found that 12(S)-HETE levels were significantly lower, higher degree of apoptosis of tumor cells and lowest rate of mitosis counts in the (Figure 4 and Table 3) Peanut oil group suggesting that inhibition of 12(S)-HETE production diminishes cell proliferation and induces apoptosis as previously described . Coincidently, high level of 12(S)-HHT could be related to increased apoptosis. These results are in agreement with previous studies that showed that lipid peroxides are selectively toxic to tumour cells by triggering apoptosis through nuclear caspase activation [43, 44]. Indeed, oxidation is the initial mechanism for inducing the phosphatidyl-serine translocation from the cytosol domain to the external membrane, considered to be a key step in the apoptotic process . Thus, lower tumor cell proliferation and enhanced apoptosis could have resulted in reduced tumour volume (Figure 2 and Figure 3). With respect to 15-LOX-1 activity, Peanut group showed significantly low levels of its major metabolite, 13-HODE. Also, this group exhibited the lowest metastasis number (Figure 2b). Although 13-HODE levels were lower in Peanut group, 13-HODE/12-HETE ratio was significantly higher (1.13) than Walnut (1.11) and Control (1.04) groups (Figure 4f). Previously, we showed that 13-HODE has anti-metastatic action, while 12(S)-HETE enhances metastasis . In addition, it was observed that mammary gland tumour cells from mice fed with ω-6 enriched diet released higher levels of 12(S)-HETE which could be linked to the high number of metastasis in this animal model . Several others showed that 12(S)-HETE is produced in large amounts by various epithelial cancer cell lines that positively correlated to their metastatic potential . The lower amounts of 15(S)-HETE noted in Peanut oil fed tumor cell group could be attributed to its anti-tumour action lending support to the previous evidence that this metabolite is present in low concentrations in different tumour tissues .
In summary, the present study showed that diets enriched with high levels of ω-9 fatty acids reduce tumour growth, metastasis and tumor leukocyte infiltration by: 1) inhibiting LOXs activity, reducing the formation of pro-tumorigenic eicosanoids such as 12 (S)-HETE and 15 (S)-HETE, 2) increasing the synthesis of 12 (S)-HHT that induces apoptosis and 3) decreasing the production of pro-inflammatory PGE2. Understanding the mechanisms by which ω-3, ω-6 and ω-9 PUFAs alter growth and trigger apoptosis of breast cancer cells is essential to devise newer dietary therapeutic strategies to prevent cancer and employ various fatty acid rich oils to potentiate the actions of the current anti-cancer therapies.
We are indebted to Mr. Ricardo Mattos for animal care. We are grateful to Dr. Constancio Giraudo for technical assistance in flow cytometry at the Fundación para el Progreso de la Medicina de la Ciudad de Córdoba- Argentina. Dr. U.N. Das is in receipt of Ramalingaswami fellowship of the Department of Biotechnology, India during the tenure of this study. This work was supported, in part, under the bilateral cooperation project between governments of India and Argentina (DST- MINCYT), ARG-RPO 033/2006). This work was supported by Grants from FONCYT, Ministerio de Ciencia y Técnica de la Provincia de Córdoba- Argentina, CONICET- Argentina and SECYT-UNC.
- International Agency for Research on Cancer. Globocan 2008, Lyon. 2008,http://www-dep.iarc.fr/
- Bidgoli SA, Ahmadi R, Zavarhei MD: Role of hormonal and environmental factors on early incidence of breast cancer in Iran. Scie Total Enviorn. 2010, 408: 4056-4061. 10.1016/j.scitotenv.2010.05.018.View ArticleGoogle Scholar
- Thiébaut AC, Chajès V, Gerber M, Boutron-Ruault MC, Joulin V, Lenoir G, Berrino F, Riboli E, Bénichou J, Clavel-Chapelon F: Dietary intakes of omega-6 and omega-3 polyunsaturated fatty acids and the risk of breast cancer. Int J Cancer. 2009, 124: 924-931. 10.1002/ijc.23980View ArticlePubMedGoogle Scholar
- Shaikh IA, Brown I, Wahle KW, Heys SD: Enhancing cytotoxic therapies for breast and prostate cancers with polyunsaturated fatty acids. Nutr Cancer. 2010, 62: 284-96. 10.1080/01635580903407189View ArticlePubMedGoogle Scholar
- Hyde CAC, Missailidis S: Inhibition of arachidonic acid metabolism and its implication on cell proliferation and tumour-angiogenesis. Intern Immunoph. 2009, 9: 701-715. 10.1016/j.intimp.2009.02.003.View ArticleGoogle Scholar
- Comba A, Pasqualini ME: Primers on Molecular Pathways - Lipoxygenases: Their Role as an Oncogenic Pathway in Pancreatic Cancer. Pancreatology. 2009, 9: 724-728. 10.1159/000235623View ArticlePubMedGoogle Scholar
- Moreno JJ: New aspects of the role of hydroxyeicosatetraenoic acids in cell growth and cancer development. Biochem Pharmacol. 2009, 77: 1-10.View ArticlePubMedGoogle Scholar
- Das UN: Influence of polyunsaturated fatty acids and their metabolites on stem cell biology. Nutrition.Google Scholar
- Zeidler R, Csanady M, Gires O, Lang S, Schmitt B, Wollenberg B: Tumour cell-derived prostaglandin E2 inhibits monocyte function by interfering with CCR5 and Mac-1. FASEB J. 2000, 17: 661-668.Google Scholar
- Tobares L, Guzmán C, Maestri DM: Effect of the Extraction and Bleaching-Processes on Jojoba (Simmondsia chinensis) Wax Quality. Eur J Lipid Sci Technol. 2003, 105: 749-753. 10.1002/ejlt.200300841.View ArticleGoogle Scholar
- Galli S, Labato MI, Bal de Kier Joffé E, Carreras MC, Poderoso JJ: Decreased mitochondrial nitric oxide synthase activity and hydrogen peroxide relate persistent tumoral proliferation to embryonic behavior. Cancer Res. 2003, 63: 6370-6377.PubMedGoogle Scholar
- Espada CE, Berra MA, Martinez MJ, Eynard AR, Pasqualini ME: Effect of Chia Oil (Salvia Hispanica) rich in n-3 fatty acids on the eicosanoid release, apoptosis and T-lymphocyte tumour infiltration in a murine mammary gland. Prost Leukot Essent Fatty Acids. 2007, 77: 21-28. 10.1016/j.plefa.2007.05.005.View ArticleGoogle Scholar
- Maestri DM, Guzmán CA: A comparative study of seed lipid components of Nicotianeae (Solanaceae). Biochem Syst Ecl. 1995, 23: 201-207. 10.1016/0305-1978(95)93850-3.View ArticleGoogle Scholar
- Calderón RO, Eynard AR: Fatty acids specifically related to the anisotropic properties of plasma membrane from rat urothelium. Biochim Biophys Acta. 2000, 1483: 174-84.View ArticlePubMedGoogle Scholar
- Kelavkar UP, Hutzley J, Mc Hugh K, Allen KGD, Parwani A: Prostate tumour growth can be modulated by dietary targeting the 15-lipoxygenase- I and cyclooxygenase-2 enzymes. Neoplasia. 2009, 11: 692-699.PubMed CentralView ArticlePubMedGoogle Scholar
- Pasqualini ME, Mohn CE, Petiti JP, Eynard AR: COX and LOX eicosanoids modulate platelet activation and procoagulation induced by two murine cancer cells. Prost Leukot Essent Fatty Acids. 2000, 63: 377-383. 10.1054/plef.2000.0228.View ArticleGoogle Scholar
- Pasqualini ME, Heyd VL, Manzo P, Eynard AR: Association between E-cadherin expression by human colon, bladder and breast cancer cells and the 13-HODE: 15-HETE ratio. A possible role of their metastatic potential. Prost Leukot Essent Fatty Acids. 2003, 68: 9-16. 10.1016/S0952-3278(02)00230-2.View ArticleGoogle Scholar
- Vermmes C, Haanen CP, Reutelingsperger M: A novel assay for apoptosis: flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J Immunol Methods. 1995, 180: 38-52.Google Scholar
- Maruoka H, Shinohara K, Miyata M, Sugimura T, Terada M, Wakasugi H: A novel monoclonal antibody permitting recognition of NKT cells in various mouse strains. Biochem Biophys Res Commun. 1998, 242: 413-418. 10.1006/bbrc.1997.7676View ArticlePubMedGoogle Scholar
- In-Kwon Y: Generalized weighted additive models based on distribution functions. Statis Probab Lett. 2007, 77: 1394-1402. 10.1016/j.spl.2007.03.029.View ArticleGoogle Scholar
- Das UN: Essential Fatty acids a review. Curr Pharm Biotechnol. 2006, 7: 467-82. 10.2174/138920106779116856View ArticlePubMedGoogle Scholar
- Das UN: Can essential fatty acids reduce the burden of disease(s)?. Lipids Health Dis. 2008, 7: 9-27. 10.1186/1476-511X-7-9PubMed CentralView ArticlePubMedGoogle Scholar
- Tapiero H, Ba GN, Coureur P, Tew KD: Polyunsaturated fatty acids (PUFAs) and eicosanoids in human health and pathologies. Biomed Pharmacol. 2000, 56: 215-222. 10.1016/S0753-3322(02)00193-2.View ArticleGoogle Scholar
- Pair R, Soreghan B, Szabo IL, Pavelka M, Baatar D, Tarnawski AS: Prostagalndin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nat Med. 2002, 8: 289-293. 10.1038/nm0302-289View ArticleGoogle Scholar
- Wang D, Dubois RN: The role of COX-2 in intestinal inflammation and colorectal cancer. Oncogene. 2010, 29: 781-788. 10.1038/onc.2009.421PubMed CentralView ArticlePubMedGoogle Scholar
- Ruhrberg C, De Palma M: Deciphering macrophage roles in human tumors. Nat Med. 2010, 16: 861-862. 10.1038/nm0810-861View ArticlePubMedGoogle Scholar
- Qualls JE, Murray PJ: Stopping macrophages wounds tumors. Nat Med. 2010, 16: 863-864. 10.1038/nm0810-863View ArticlePubMedGoogle Scholar
- Tashjian AH, Voelkel EF, Lazzaro M, Goad D, Bosma T, Levine L: Tumor necrosis factor-alpha (cachectin) stimulates bone resorption in mouse calvaria via a prostaglandin-mediated mechanism. Endocrinology. 1987, 120: 2029-2036. 10.1210/endo-120-5-2029View ArticlePubMedGoogle Scholar
- Alleva DG, Burger CJ, Elgert KD: Tumor growth increases Ia- macrophage synthesis of tumor necrosis factor-alpha and prostaglandin E2: changes in macrophage suppressor activity. J Leukoc Biol. 1993, 53: 550-558.PubMedGoogle Scholar
- Karck U, Peters T, Decker K: The release of tumor necrosis factor from endotoxin-stimulated rat Kupffer cells is regulated by prostaglandin E2 and dexamethasone. J Hepatol. 1988, 7: 352-361. 10.1016/S0168-8278(88)80008-4View ArticlePubMedGoogle Scholar
- Ben-Efraim S, Bonta IL: Modulation of antitumour activity of macrophages by regulation of eicosanoids and cytokine production. Int J Immunopharmacol. 1994, 16: 397-399. 10.1016/0192-0561(94)90027-2View ArticlePubMedGoogle Scholar
- Chae BS, Shin TY, Kim DK, Eun JS, Leem JY, Yang JH: Prostaglandin E2-mediated dysregulation of proinflammatory cytokine production in pristane-induced lupus mice. Arch Pharm Res. 2008, 31: 503-510.View ArticlePubMedGoogle Scholar
- Palombella VJ, Vilcek J: Mitogenic and cytotoxic actions of tumor necrosis factor in BALB/c 3T3 cells. Role of phospholipase activation. J Biol Chem. 1989, 264: 18128-18136.PubMedGoogle Scholar
- Suffys P, Beyaert R, Van Roy F, Fiers W: Reduced tumour necrosis factor-induced cytotoxicity by inhibitors of the arachidonic acid metabolism. Biochem Biophys Res Commun. 1987, 149: 735-743. 10.1016/0006-291X(87)90429-3View ArticlePubMedGoogle Scholar
- Suffys P, Beyaert R, De Valck D, Vanhaesebroeck B, Van Roy F, Fiers W: Tumour-necrosis-factor-mediated cytotoxicity is correlated with phospholipase-A2 activity, but not with arachidonic acid release per se. Eur J Biochem. 1991, 195: 465-475. 10.1111/j.1432-1033.1991.tb15727.xView ArticlePubMedGoogle Scholar
- Neale ML, Fiera RA, Matthews N: Involvement of phospholipase A2 activation in tumour cell killing by tumour necrosis factor. Immunology. 1988, 64: 81-85.PubMed CentralPubMedGoogle Scholar
- Watanabe S, Onozaki K, Yamamoto S, Okuyama H: Regulation by dietary essential fatty acid balance of tumor necrosis factor production in mouse macrophages. J Leukoc Biol. 1993, 53: 151-156.PubMedGoogle Scholar
- Tappia PS, Man WJ, Grimble RF: Influence of unsaturated fatty acids on the production of tumour necrosis factor and interleukin-6 by rat peritoneal macrophages. Mol Cell Biochem. 1995, 143: 89-98. 10.1007/BF01816941View ArticlePubMedGoogle Scholar
- Kumar GS, Das UN: Effect of prostaglandins and their precursors on the proliferation of human lymphocytes and their secretion of tumor necrosis factor and various interleukins. Prostaglandins Leukot Essent Fatty Acids. 1994, 50: 331-334. 10.1016/0952-3278(94)90242-9View ArticlePubMedGoogle Scholar
- Das UN: Tumoricidal action of cis-unsaturated fatty acids and their relationship to free radicals and lipid peroxidation. Cancer Lett. 1991, 56: 235-243. 10.1016/0304-3835(91)90008-6View ArticlePubMedGoogle Scholar
- Das UN, Prasad VV, Reddy DR: Local application of gamma-linolenic acid in the treatment of human gliomas. Cancer Lett. 1995, 94: 147-155. 10.1016/0304-3835(95)03844-MView ArticlePubMedGoogle Scholar
- Nazarewicz RR, Zenebe WJ, Parihar A, Parihar MS, Vaccaro M, Rink C, Sen CK, Ghafourifar P: 12(S)-hydroperoxyeicosatetraenoic acid (12-HETE) increases mitochondrial nitric oxide by increasing intramitochondrial calcium. Arch Biochem Biophys. 2007, 468: 114-20. 10.1016/j.abb.2007.09.018PubMed CentralView ArticlePubMedGoogle Scholar
- Das UN: Essential fatty acids, lipid peroxidation and apoptosis. Prostaglandins Leukot Essen Fatty Acids. 1999, 61: 157-63. 10.1054/plef.1999.0085.View ArticleGoogle Scholar
- Uauy R, Solomons N: Diet, Nutrition, and the life-course approach to cancer prevention. J Nutr. 2005, 135: 2934S-2945S.PubMedGoogle Scholar
- Zuo X, Wu Y, Morris JS, Stimmel JB, Leesnitzer LM, Fischer SM, Lippman SM, Shureiqi I: Oxidative metabolism of linoleic acid modulates PPAR-beta/delta suppression of PPAR-gamma activity. Oncogene. 2006, 25: 1225-1241. 10.1038/sj.onc.1209160PubMed CentralView ArticlePubMedGoogle Scholar
- Nie D, Krishnamoorthy S, Jin R, Tang K, Chen Y, Qiao Y, Zacharek A, Guo Y, Milanini J, Pages G, Honn KV: Mechanisms regulating tumour angiogenesis by 12-lipoxygenase in prostate cancer cells. J Biol Chem. 2006, 281: 18601-18609. 10.1074/jbc.M601887200View ArticlePubMedGoogle Scholar
- Srivastava K, Kundumani-Sridharan V, Zhang B, Bajpai AK, Rao GN: 15(S)-Hydroxyeicosatetraenoic Acid-Induced Angiogenesis Requires STAT3-Dependent Expression of VEGF. Cancer Res. 2007, 67: 4328-4336. 10.1158/0008-5472.CAN-06-3594View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.